SG Americas Securities
MRNA icon

SG Americas Securities’s Moderna MRNA Stock Holding History

SG Americas Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
780,000
+730,500
+1,476% +$34.1M ﹤0.01% 1626
2025
Q4 		$3K Buy
+49,500
New +$1.34M ﹤0.01% 3556
2025
Q2 		– Sell
-520,000
Closed -$4.75M – 3348
2025
Q1 		$4.75M Buy
520,000
+494,800
+1,963% +$17.6M 0.02% 486
2024
Q4 		$1.03M Sell
25,200
-22,000
-47% -$1.05M ﹤0.01% 853
2024
Q3 		$1.09M Buy
47,200
+30,000
+174% +$2.75M ﹤0.01% 1020
2024
Q2 		$50K Sell
17,200
-43,900
-72% -$5.56M ﹤0.01% 2672
2024
Q1 		$487K Buy
61,100
+12,300
+25% +$1.24M ﹤0.01% 1438
2023
Q4 		$868K Sell
48,800
-9,300
-16% -$782K 0.01% 1103
2023
Q3 		$1.3M Buy
58,100
+19,100
+49% +$2.13M 0.01% 1061
2023
Q2 		$694K Buy
39,000
+21,400
+122% +$2.85M 0.01% 1245
2023
Q1 		$332K Buy
17,600
+9,300
+112% +$1.53M ﹤0.01% 2049
2022
Q4 		$112K Buy
+8,300
New +$1.36M ﹤0.01% 2643
2022
Q3 		– Sell
-182,500
Closed -$4.35M – 3417
2022
Q2 		$4.35M Sell
182,500
-610,000
-77% -$87.2M 0.05% 341
2022
Q1 		$10.4M Buy
792,500
+732,400
+1,219% +$123M 0.08% 208
2021
Q4 		$3.4M Sell
60,100
-92,900
-61% -$27.2M 0.02% 705
2021
Q3 		$9.78M Buy
+153,000
New +$56.4M 0.05% 273

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's MRNA Position: Q1 2026 in Review

SG Americas Securities reduced its Moderna (MRNA) stake by 10% in Q1 2026, selling an estimated $1.3M and leaving 250,868 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #704.

SG Americas Securities first reported a position in MRNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $34.4M in Q1 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • SG Americas Securities held 250,868 shares of Moderna worth $12.7M as of Q1 2026.
  • SG Americas Securities sold 27,930 Moderna shares in Q1 2026, an estimated $1.3M.
  • Moderna made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #704 holding.
  • SG Americas Securities first reported a position in Moderna in Q2 2020 and has held it in 24 quarters since.
  • SG Americas Securities's Moderna position peaked at $34.4M in Q1 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.